3/30
09:49 am
rckt
Rocket Pharmaceuticals (RCKT) had its price target raised by Bank of America Corporation from $8.00 to $9.00. They now have a "buy" rating on the stock.
Medium
Report
Rocket Pharmaceuticals (RCKT) had its price target raised by Bank of America Corporation from $8.00 to $9.00. They now have a "buy" rating on the stock.
3/29
05:02 pm
rckt
Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI [Yahoo! Finance]
Medium
Report
Why Rocket Pharmaceuticals (RCKT) Got a Commercial Boost From FDA Approval of KRESLADI [Yahoo! Finance]
3/29
03:03 pm
rckt
Rocket Pharmaceuticals (RCKT) Is Down 8.9% After FDA Accelerated Approval Of KRESLADI Gene Therapy [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals (RCKT) Is Down 8.9% After FDA Accelerated Approval Of KRESLADI Gene Therapy [Yahoo! Finance]
3/29
09:32 am
rckt
Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited [Seeking Alpha]
Medium
Report
Rocket Pharmaceuticals: Kresladi Approval Validates Platform, But Commercial Upside Remains Limited [Seeking Alpha]
3/27
02:24 pm
rckt
Rocket Pharmaceuticals (RCKT) had its "buy" rating reaffirmed by Chardan Capital. They now have a $11.00 price target on the stock.
Low
Report
Rocket Pharmaceuticals (RCKT) had its "buy" rating reaffirmed by Chardan Capital. They now have a $11.00 price target on the stock.
3/27
10:23 am
rckt
Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals secures FDA approval for gene therapy KRESLADI [Yahoo! Finance]
3/27
07:46 am
rckt
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) [Yahoo! Finance]
Low
Report
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I) [Yahoo! Finance]
3/27
07:00 am
rckt
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
High
Report
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
3/8
01:31 am
rckt
Medium
Report
3/3
01:30 pm
rckt
Wedbush sees Rocket Pharmaceuticals as significantly undervalued as cardiac gene therapy pipeline advances [Yahoo! Finance]
Low
Report
Wedbush sees Rocket Pharmaceuticals as significantly undervalued as cardiac gene therapy pipeline advances [Yahoo! Finance]
3/2
12:36 pm
rckt
Rocket Pharmaceuticals (RCKT) had its price target raised by The Goldman Sachs Group, Inc. from $2.00 to $3.00. They now have a "sell" rating on the stock.
Low
Report
Rocket Pharmaceuticals (RCKT) had its price target raised by The Goldman Sachs Group, Inc. from $2.00 to $3.00. They now have a "sell" rating on the stock.
2/28
05:57 am
rckt
Rocket Pharmaceuticals (RCKT) was upgraded by Lifesci Capital to "strong-buy".
Low
Report
Rocket Pharmaceuticals (RCKT) was upgraded by Lifesci Capital to "strong-buy".
2/27
03:02 pm
rckt
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus [Yahoo! Finance]
Low
Report
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus [Yahoo! Finance]
2/27
09:47 am
rckt
Rocket Pharmaceuticals (RCKT) had its price target raised by Cantor Fitzgerald from $8.00 to $10.00. They now have an "overweight" rating on the stock.
Medium
Report
Rocket Pharmaceuticals (RCKT) had its price target raised by Cantor Fitzgerald from $8.00 to $10.00. They now have an "overweight" rating on the stock.
2/26
04:14 pm
rckt
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]
High
Report
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress [Yahoo! Finance]
2/26
04:00 pm
rckt
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
High
Report
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
2/23
07:17 am
rckt
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/23
07:00 am
rckt
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences
Medium
Report
Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences